ORLANDO, Fla — A new analysis of a major study of the long-term effects of bariatric surgery failed to prove a mental health benefit for this...
During a lecture at the 2024 International Congress on Obesity in São Paulo, Brazil, Dr Carel Le Roux, a South African researcher, reflected on the Stratification...
Please note that the text below is not a full transcript and has not been copyedited. For more insight and commentary on these stories, subscribe to...
In 2010, Brazilian epidemiologist Dr Carlos Monteiro, scientific coordinator of the Nutritional Epidemiology Research Center at the University of São Paulo in Brazil, gained global recognition...
ORLANDO, Florida — What to prioritize first in managing early diabetes? That was the question debated on an expert panel at the American Diabetes Association (ADA)...
MONTREAL —Tirzepatide (Mounjaro, Eli Lilly), the dual gastric inhibitory polypeptide–glucagon-like peptide 1 (GIP–GLP-1) receptor agonist that has shown significant benefits in diabetes and obesity, may also...
LYON, France — Bempedoic acid ( Nexletol) is safe for people with obesity and is effective at lowering lipid levels and rates of major cardiovascular events,...
ORLANDO, Fla. — The glucagon-like peptide 1 (GLP-1) receptor agonist semaglutide (Wegovy, Ozempic) reduced cardiovascular events and reduced the risk of progression to diabetes by 73%...
Weight loss achieved through bariatric surgery lowered the risk of major adverse cardiovascular events (MACE) by 42% and all-cause mortality by 37% in people who were...
ORLANDO, FL — The diabetes and weight loss drug tirzepatide (Mounjaro for type 2 diabetes; Zepbound for obesity) was so effective at reducing sleep disruptions in...
The prevention of cardiovascular diseases is a significant public health problem. Systemic arterial hypertension is a well-recognized risk factor for cardiovascular diseases worldwide. At birth, most...
TOPLINE: Bariatric metabolic surgery (BMS) offers a survival advantage over glucagon-like peptide 1 receptor agonists (GLP-1 RAs) in adults with obesity and diabetes for ≤ 10...